2000 Senior Research Award Winners
Dharminder Chauhan, PhD
Dana Farber Cancer Institute
"Apoptotic and Survival Proteins as Novel Therapeutic Targets in Multiple Myeloma."
Awarded Second Year of Funding
Alan Lichtenstein, MD
VA West LA Hospital- UCLA Medical School
"AKT/p70S6K/4E-BPI Cascade in Multiple Myeloma"
Diane Jellinek, PhD
Mayo Clinic
"Identification of Gene Expression Patterns Associated with Prognosis and Outcome in Multiple Myeloma"
G. David Roodman, MD, PhD
University of Texas Health Science Center of San Antonio
"Role of MIP-1a in Myeloma Bone Disease"
Awarded Second Year of Funding
Joachim Schultze, MD
Dana-Farber Cancer Institute
"Determination of Antigen-Specific Immunity in Myeloma Patients"
Freda Stevenson, DPhil and Francesco Forconi, MD
University of Southampton, UK
"Development and Trial of DNA Vaccines Against Multiple Myeloma"
Awarded Second Year of Funding
Brian Van Ness, PhD
University of Minnesota
"Profiling IL-6 and Stromal Induced Gene Expression and Signal Transduction in Myeloma Cell Lines"
Awarded Second Year of Funding
Helena Jemberg Wiklund, PhD
Uppsala University, Sweden
"The Control of Proliferation, Survival and Apoptosis in Multiple Myeloma"
Qing Yi, MD, PhD
University of Arkansas for Medical Science
"Optimization of Dendritic Cell-Based Immunotherapy in Multiple Myeloma"
2000 Fellows' Award Winners
Marleen Bakkus, MD, PhD
Free University, Brussels
"Study of the Existence of Abnormal IgH Chromosomal Rearrangements and at the Occurence of Isotype-Switch Variants in the 5T Myeloma Mouse Model. "
Satish Kumar, MD
University of Oklahoma Health Science Center
"Mechanism of Kidney Failure in Multiple Myeloma."
Britta Maecker, MD
Dana Farber Cancer Institute
"Analysis of CYP1B1 Specific T Cells in Multiple Myeloma Patients."
Yu-Tzu Tai, PhD
Dana-Farber Cancer Institute
"The Role of Ku86v in the Pathogenesis of Mutliple Myeloma."
Youzhi Tong, PhD
North Shore LIJ Health System
"Dendritic Cell Strategies Combined With Chemotherapy Against Multiple Myeloma"
Jin Yi Wang, MD, PhD
University of Arkansas for Medical Sciences
"Stahmin: A Novel Target for Multiple Myeloma Therapy."